Penelitian ini bertujuan untuk mengetahui status lcardiovaskular pada neonatus kurang bulan (NKB) dengan penyakit membran hialin (PMH) 
METHODS
Design and study subjects
The study was conducted at Dr. Cipto Mangunkusumo Hospital, Jakarta, from November 1987 to May 1998. To be eligible for the study a preterm infant with mild HMD had to be more than 1250 grams in weight and less than 48 hours in age at the time of enrollment.
Twins, patients with overt chromosomal syndrome, those with congenital heart disease other than patent ductus arteriosus, and those with congenital anomaly were excluded from the study.
The study comprised 2 parts. The first part was a cross sectional study to compare ventricular function (VF) and cerebral blood flow velocity (CBFV) of preterm infants with mild HMD and those withour HMD. For this purpose, preterm infants with mild HMD were compared with their matched controls, i.e. preterm infants without HMD. The matching variables were birth weight (+ 100 grams) and gestational age (+ 2 weeks).
The second part was an interventional physiological study using randomized, double blind, placebo-controlled trial with cross-over design. For this pu{pose, all preterm infants with mild HMD who met the study criteria were subjects for VF and CBFV examinations.
Thereafter, they were randomized by computer generated simple randomization scheme, to either Table 5 shows comparison of vital signs between both groups. Dobutamine administration changed mean heart rate and mean respiratory rate significantly, as well as the means systolic, diastolic, and mean arterial pressures. Increase in mean arterial pressure has been the expected effect of dobutamine administration, and has been used as a parameter for inotropic effect to increase blood pressure in preterm infants with hypotension .23'24'It should be mentioned that in placebo group, the mean arterial pressure was 39 mmHg, while the critical value for mean arterial pressure in preterm infants is 30 mmHg.24 It ,n"un, that in this series no patient was hypotensive, which is commonly found in severe HMD. Increase in heart rate in study accords with the report of Barre et a1.,25 but inconsistent with other's,'* that compared with Effects of dobutamine on cardiovascular functions in mild HMD 223 dopamine, dobutamine increases mean arterial pressure without increasing heart rate significantly.
RV diastolic functions were compared in 34 pairs of infants with mild HMD. Table 6 shows that dobutamine administration increased mean point E minimally (from 26 to 29 mmHg), and also increased mean point A minimally (from 32 to 35 mmHg); both changes were not significant. Different results were found in the response of LV diastolic functions (Table   7) . Data showed that dobutamine increased significantly the mean diastolic filling velocity, both point E (ftom 42 to 47 cm/sec) and point A (from 38 to 41 cm/sec).
lnterpretation of ventricular diastolic function is not a simple one, since it is influenced by many factors, one of them is diastolic filling.'" Theoretically inotropic drug with positive chronotropic effect may disturb ventricular diastolic function, because it decreases diastolic filling time. However, in study this not the case, because increase in points E and A was larger than increase of heart rate. In Table 5 and Table 7 
